Stocks
PTC Therapeutics, Inc.PTCT
NASDAQHealthcareBiotechnology$68.13
A biotechnology company focused on developing therapies for rare genetic disorders, particularly those caused by nonsense mutations and defects in RNA splicing. Its portfolio includes approved treatments and a pipeline targeting neuromuscular and metabolic diseases, with regulatory decisions and cli...
52W Range: $35.95 – $87.50
Congressional Interest in PTC Therapeutics, Inc. (PTCT)
No congressional trades have been disclosed for PTC Therapeutics, Inc. (PTCT) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading PTCT?
No congressional trades found for this stock.